Bank of America Corp DE reduced its stake in Rezolute, Inc. (NASDAQ: RZLT) by 31.3% during the undef

Dow Jones index gained around 350 points on Friday. MARA Holdings Inc (NASDAQ: MARA) rose sharply, w

REDWOOD CITY, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Presentations included analyses of natural history and adverse outcomes in congenital hyperinsulinis

Presentations included analyses of natural history and adverse outcomes in congenital hyperinsulinis

Guggenheim analyst Debjit Chattopadhyay maintains Rezolute (NASDAQ:RZLT) with a Buy and raises th

Rezolute rises 38% in a week after interim upLIFT data shows most tumor HI patients cut or eliminate

Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage ultra-rare

REDWOOD CITY, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Maxim Group analyst Jason McCarthy maintains Rezolute (NASDAQ:RZLT) with a Buy and raises the pri

Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY

Citizens analyst Jason N. Butler upgrades Rezolute (NASDAQ:RZLT) from Market Perform to Market Ou

Wedbush analyst Yun Zhong maintains Rezolute (NASDAQ:RZLT) with a Outperform and raises the price

U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock

Rezolute, Inc. (NASDAQ:RZLT) reported an interim update from its ongoing Phase 3 upLIFT study evalua

Rezolute says 6 of 8 patients met the primary endpoint in its Phase 3 upLIFT study of ersodetug for

HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and mai

Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage ultra-rare

Study now 50% enrolled 6 of 8 participants have already met the responder criterion for the study's

Maxim Group analyst Jason McCarthy maintains Rezolute (NASDAQ:RZLT) with a Buy and raises the pri

Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.16) per share which met the analyst consensu

REDWOOD CITY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

REDWOOD CITY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrat

Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrat

LOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Rezolute, Inc., (“Rezol

Oral presentation will include previously announced topline results as well as pre-specified and pos

Oral presentation will include previously announced topline results as well as pre-specified and pos

RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earli

Wedbush analyst Yun Zhong upgrades Rezolute (NASDAQ:RZLT) from Neutral to Outperform and raises t

In a recent update, Rezolute shared insights from its March 17 meeting with the FDA regarding its Ph

Rezolute shares rise after FDA feedback on sunRIZE trial; mixed efficacy, data review ahead for rare

Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage rare diseas

REDWOOD CITY, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o

ADMA Biologics (NASDAQ: ADMA - Get Free Report) and Rezolute (NASDAQ: RZLT - Get Free Report) are bo

NEW YORK--(BUSINESS WIRE)---- $RZLT #ClassAction--Faruqi & Faruqi, LLP, a leading national securitie

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson  Encourages Investors Who Suf

REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o

Faruqi & Faruqi, LLP Securities Litigation Partner  James (Josh) Wilson Encourages Investors Who Suf

Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.22) per share which missed the analyst conse

Wedbush analyst Yun Zhong maintains Rezolute (NASDAQ:RZLT) with a Neutral and raises the price ta

Guggenheim analyst Debjit Chattopadhyay maintains Rezolute (NASDAQ:RZLT) with a Buy and lowers th

HC Wainwright & Co. analyst Douglas Tsao maintains Rezolute (NASDAQ:RZLT) with a Buy and lowe

XOMA stock plunged after its partner Rezolute Inc. reported disappointing trial results for their pr

Rezolute sinks after its Phase 3 congenital hyperinsulinism trial showed no statistically significan